Found 65 matching trials
T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 Positive PHASE1 Background:
The National Cancer Institute (NCI) Surgery Branch has develop...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Gene-Modified White Blood Cells Followed By Interleukin-2 and Vaccine Therapy in Treating Patients With Metastatic Melanoma PHASE1 RATIONALE: Inserting a gene that has been created in the laboratory into a ...
Show More Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Learn More & Join Trial
Bispecific Antibody-Based Salvage Therapy Followed by CAR-T ± ASCT in R/R Aggressive B-Cell Lymphoma PHASE2 This study consists of two sequential treatment phases. In the first phase,...
Show More Location
Institute of Hematology & Blood Diseases Hospital
Learn More & Join Trial
Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy PHASE3 The goal of this clinical study is to compare the study drug KITE-753 versu...
Show More Location
City of Hope Arizona
Learn More & Join Trial
Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer PHASE1 This clinical trial will evaluate the safety and activity of mutant KRAS G1...
Show More Location
Changhai Hospital
Learn More & Join Trial
A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia PHASE1 The researchers are doing this study is to find the highest dose of cytokin...
Show More Location
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)
Learn More & Join Trial
Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With IgG4-Related Disease PHASE1 ACE1831 is an off-the-shelf, allogeneic gamma delta T (gdT) cell therapy de...
Show More Learn More & Join Trial
CAR T Cell Receptor Immunotherapy Targeting VEGFR2 for Patients With Metastatic Cancer PHASE1 Background:
The National Cancer Institute (NCI) Surgery Branch has develop...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Registry of Patients Having Received oNKord® N/A ReKORD is an observational study (Registry) enrolling participants who have...
Show More Location
Medizinische Hochschule Hannover
Learn More & Join Trial
Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic Melanoma PHASE1 RATIONALE: Inserting a laboratory-treated gene into a person's white blood ...
Show More Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Learn More & Join Trial